✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Chemo-Pharma Laboratories Ltd.

CHEMOPH

Market Cap
₹20 Cr.
P/E
52.02

Chemo-Pharma Laboratories Ltd.

  • Chemo Pharma Labs
  • Phaarmasia
  • Hamps Bio
FAQs on Chemo-Pharma Laboratories Ltd. Shareprice

Chemo Pharma Labs has given better returns compared to its competitors.
Chemo Pharma Labs has grown at ~61.54% over the last 1yrs while peers have grown at a median rate of -9.0%

Chemo Pharma Labs is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Chemo Pharma Labs is 51.02, while 3 year average PE is 25.88.
Also latest EV/EBITDA of Chemo Pharma Labs is 0.0 while 3yr average is 3.01.

View FAQ's On Business
Growth Table
  • Chemo-Pharma Laboratories Ltd.
  • Phaarmasia
  • Hamps Bio
Balance Sheet
  • Chemo-Pharma Laboratories Ltd.
  • Phaarmasia
  • Hamps Bio
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Chemo-Pharma Laboratories Ltd.
  • Phaarmasia
  • Hamps Bio
Cash Flow
  • Chemo-Pharma Laboratories Ltd.
  • Phaarmasia
  • Hamps Bio
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Chemo-Pharma Laboratories Ltd.
  • Phaarmasia
  • Hamps Bio
Quarterly Results
  • Chemo-Pharma Laboratories Ltd.
  • Phaarmasia
  • Hamps Bio
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Chemo-Pharma Laboratories Ltd. Financials

Chemo Pharma Labs balance sheet is weak and might have solvency issues

Yes, The debt of Chemo Pharma Labs is increasing.
Latest debt of Chemo Pharma Labs is -₹6.75 Crs as of Sep-24.
This is greater than Mar-24 when it was -₹12.21 Crs.

The profit is oscillating.
The profit of Chemo Pharma Labs is ₹1.2 Crs for Mar 2024, ₹0.05 Crs for Mar 2023 and ₹0.56 Crs for Mar 2022

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Chemo Pharma Labs latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech